AstraZeneca collaborates with Cambridge medical analysis institutions to advance tumor research AstraZeneca today announced that it has entered into an contract with the University of Cambridge and Cancers Analysis UK for a two-year collaboration on 3 pre-clinical and clinical oncology tasks . This contract with world-leading medical analysis institutions located in Cambridge, UK, aims to advance cancer study through the scholarly research of tumour mutations and brand-new investigational therapies in prostate, pancreatic and additional cancers potentially. This alliance provides together researchers from AstraZeneca’s little molecule and MedImmune’s biologics systems and researchers over the area from the University, affiliated Institutes and the NHS, which are people of the Cambridge Tumor Centre.

Other articles from category "gastroenterology":

Random articles